Ireland’s pharma success meets Washington’s tariff plans
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report is about tariffs and trade and pharma and health.
Directly affected
- No company is named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR-0.4% 30d
Industrial Select Sector SPDR: it holds companies hit by import costs and trade rules. Linked by “tariff” (tariffs and trade) in this story.
- XRT SPDR S&P Retail ETF
SPDR S&P Retail ETF: it holds companies hit by import costs and trade rules. Linked by “tariff” (tariffs and trade) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- VGK Vanguard FTSE Europe ETF
Vanguard FTSE Europe ETF holds stocks listed in Europe, which this story is about (“ireland”).
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- CAT Caterpillar-28.4% 30d
Caterpillar (construction machinery and equip): importers and exporters pay or lose sales when tariffs change. Linked by “tariff” (tariffs and trade) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLI | -3.98% | -0.39% | base | -0.70% | after close | after close | after close |
| XRT | -1.32% | +1.93% | base | -0.28% | after close | after close | after close |
| XLV | -1.60% | +0.57% | base | +0.19% | after close | after close | after close |
| VGK | -1.80% | +0.84% | base | +0.02% | after close | after close | after close |
| LLY | -5.27% | +0.16% | base | +0.29% | after close | after close | after close |
| JNJ | -2.55% | -0.98% | base | +1.29% | after close | after close | after close |
| CAT | -7.69% | -3.42% | base | -1.78% | after close | after close | after close |
| PFE | +1.93% | +1.84% | base | -0.03% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Ireland’s pharma success meets Washington’s tariff plans The Pharma Letter
Source: The Pharma Letter
Select Sector Spdr Tr (XLI) since “Ireland’s pharma success meets Washington’s tariff plans,” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Caterpillar (CAT) | that day | -1.78% | still updating |
| Caterpillar (CAT) | three days earlier | -3.42% | final price |
| Caterpillar (CAT) | five days earlier | -7.69% | final price |
| Johnson & Johnson (JNJ) | that day | +1.29% | still updating |
| Johnson & Johnson (JNJ) | three days earlier | -0.98% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -2.55% | final price |
| Eli Lilly (LLY) | that day | +0.29% | still updating |
| Eli Lilly (LLY) | three days earlier | +0.16% | final price |
| Eli Lilly (LLY) | five days earlier | -5.27% | final price |
| Pfizer (PFE) | that day | -0.03% | still updating |
| Pfizer (PFE) | three days earlier | +1.84% | final price |
| Pfizer (PFE) | five days earlier | +1.93% | final price |
| Vanguard Intl Equity Index F (VGK) | that day | +0.02% | still updating |
| Vanguard Intl Equity Index F (VGK) | three days earlier | +0.84% | final price |
| Vanguard Intl Equity Index F (VGK) | five days earlier | -1.80% | final price |
| Select Sector Spdr Tr (XLI) | that day | -0.70% | still updating |
| Select Sector Spdr Tr (XLI) | three days earlier | -0.39% | final price |
| Select Sector Spdr Tr (XLI) | five days earlier | -3.98% | final price |
| Select Sector Spdr Tr (XLV) | that day | +0.19% | still updating |
| Select Sector Spdr Tr (XLV) | three days earlier | +0.57% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -1.60% | final price |
| Spdr Series Trust (XRT) | that day | -0.28% | still updating |
| Spdr Series Trust (XRT) | three days earlier | +1.93% | final price |
| Spdr Series Trust (XRT) | five days earlier | -1.32% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 24 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 70 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 37 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 44 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lisa McClain bought Caterpillar (CAT) (held by a spouse), worth $1,001 - $15,000 on 28 Sep 2026. That is 46 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 70 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 84 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLI)
Companies tied to this story
- XLI Select Sector Spdr Tr
Select Sector Spdr Tr (XLI) is linked, with no stored direction, medium confidence in the 13 Nov 2026 story “Ireland’s pharma success meets Washington’s tariff plans.” Reason on file: Industrial Select Sector SPDR: it holds companies hit by import costs and trade rules. Linked by “tariff” (tariffs and trade) in this story
- XRT Spdr Series Trust
In “Ireland’s pharma success meets Washington’s tariff plans,” Spdr Series Trust (XRT) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Retail ETF: it holds companies hit by import costs and trade rules. Linked by “tariff” (tariffs and trade) in this story
- XLV Select Sector Spdr Tr
For “Ireland’s pharma success meets Washington’s tariff plans,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
- VGK Vanguard Intl Equity Index F
In “Ireland’s pharma success meets Washington’s tariff plans,” Vanguard Intl Equity Index F (VGK) is linked, with no stored direction, medium confidence. Reason on file: Vanguard FTSE Europe ETF holds stocks listed in Europe, which this story is about (“ireland”)
- LLY Eli Lilly
In “Ireland’s pharma success meets Washington’s tariff plans,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- JNJ Johnson & Johnson
In “Ireland’s pharma success meets Washington’s tariff plans,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- CAT Caterpillar
In “Ireland’s pharma success meets Washington’s tariff plans,” Caterpillar (CAT) is linked, with no stored direction, medium confidence. Reason on file: Caterpillar (construction machinery and equip): importers and exporters pay or lose sales when tariffs change. Linked by “tariff” (tariffs and trade) in this story
- PFE Pfizer
In “Ireland’s pharma success meets Washington’s tariff plans,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
How “Ireland’s pharma success meets Washington’s tariff plans” reaches Select Sector Spdr Tr (XLI)
The 13 Nov 2026 story “Ireland’s pharma success meets Washington’s tariff plans” names Select Sector Spdr Tr (XLI) because of this story.
For Select Sector Spdr Tr (XLI), the reason on file says Industrial Select Sector SPDR: it holds companies hit by import costs and trade rules. Linked by “tariff” (tariffs and trade) in this story
Also listed, Spdr Series Trust (XRT): SPDR S&P Retail ETF: it holds companies hit by import costs and trade rules. Linked by “tariff” (tariffs and trade) in this story
Dates and price levels for Select Sector Spdr Tr (XLI)
XLI traded between 163.00 and 172.33 across 20 sessions. The latest close on file is 169.73.
How solid “Ireland’s pharma success meets Washington’s tariff plans” looks
46 out of 100Price not final
“Ireland’s pharma success meets Washington’s tariff plans” scores 46 out of 100. The score uses 1 sources, and 8 linked companies. The price is not final yet.